Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universite Antilles Guyane currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being reviewed by 1 distinct examiner within 1 distinct art unit. The current scope of the company's patent prosecution is limited to this single active application. This indicates a highly concentrated prosecution footprint, where the company's current interactions with the patent office are limited to a single point of contact.
The busiest examiner for the portfolio is LEE, WILLIAM Y, who is responsible for the 1 pending office action. With only 1 distinct examiner involved, the company has a single point of contact for its current patenting efforts. Practitioners should monitor the specific feedback from this examiner to determine the best path forward for the pending matter. Because the portfolio is limited to 1 distinct art unit, the prosecution strategy can focus on the specific rules and trends of that group. Effectively managing the 1 pending office action is critical for the company's current intellectual property objectives in the biotechnology sector. The limited scope of the portfolio allows for a deep analysis of past decisions made within the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 1 | 48.0% | +34.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257438 | USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES | LEE, WILLIAM Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257438 | USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257438 | USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES | LEE, WILLIAM Y | 1623 | §102§103 | Non-Final OA | — | Pending | Jun 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversite Antilles Guyane has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William Y Lee has the most, with 1 of Universite Antilles Guyane's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
